Thông tin tài liệu
Thông tin siêu dữ liệu biểu ghi
| Trường DC | Giá trị | Ngôn ngữ |
|---|---|---|
| dc.contributor.author | Tom D. Y., Reijnders | - |
| dc.contributor.author | Hessel, Peters-Sengers | - |
| dc.contributor.author | Tom van der, Poll | - |
| dc.date.accessioned | 2023-03-21T04:50:48Z | - |
| dc.date.available | 2023-03-21T04:50:48Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.uri | https://link.springer.com/article/10.1186/s13054-023-04359-z | - |
| dc.identifier.uri | https://dlib.phenikaa-uni.edu.vn/handle/PNK/7019 | - |
| dc.description | CC BY | vi |
| dc.description.abstract | We appreciate the insightful comments by Prof. Honoré and colleagues regarding our target trial emulation on the effect of erythromycin in critically ill patients with sepsis [1, 2]. Prof. Honoré and colleagues suggest that, in theory, removal of erythromycin from the circulation by renal replacement therapy (RRT) could dilute the potential effect of erythromycin, and that it may therefore be necessary to exclude patients undergoing RRT. | vi |
| dc.language.iso | en | vi |
| dc.publisher | Springer | vi |
| dc.subject | renal replacement therapy | vi |
| dc.subject | removal of erythromycin | vi |
| dc.title | No evidence for relevant impact of renal replacement therapy on clinical effect of erythromycin in critically ill patients with sepsis | vi |
| dc.type | Book | vi |
| Bộ sưu tập | ||
| OER- Y học- Điều dưỡng | ||
Danh sách tệp tin đính kèm:
